(IHF) iShares U.S. Healthcare - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642888287

Healthcare, Providers, Stocks, U.S., Sector

Description: IHF iShares U.S. Healthcare

The iShares U.S. Healthcare Providers ETF (IHF) is designed to track the performance of the healthcare providers sector in the U.S. equity market, as defined by S&P Dow Jones Indices. By investing at least 80% of its assets in the component securities of its index, the fund provides exposure to a specific segment of the healthcare industry. The remaining 20% can be invested in derivatives such as futures, options, and swap contracts, as well as cash and cash equivalents, allowing for flexibility in managing the portfolio.

The healthcare providers sector includes companies involved in delivering healthcare services, such as hospitals, nursing homes, and healthcare facilities. The funds focus on this specific area allows investors to tap into the growth potential of the healthcare industry, driven by factors such as an aging population and increasing demand for healthcare services. As a non-diversified fund, IHF is more concentrated in its holdings, which can result in higher volatility.

Analyzing the , we observe that the last price of IHF is $47.73, slightly above its 20-day simple moving average (SMA) of $47.43, indicating a potential bullish trend. However, the 50-day SMA ($48.74) and 200-day SMA ($51.59) are above the current price, suggesting a longer-term downtrend. The average true range (ATR) of 0.91 represents a 1.90% daily price range, indicating moderate volatility. Considering the , the funds assets under management (AUM) stand at $654.10 million, providing a reasonable level of liquidity.

Forecasting the future performance of IHF, we can expect the fund to be influenced by the overall trend in the healthcare providers sector. If the sector continues to grow, driven by demographic changes and healthcare reform, IHF is likely to benefit. However, the current technical indicators suggest a short-term bullish trend, while the longer-term trend remains bearish. Therefore, a potential trading strategy could involve monitoring the funds price action around its SMAs and adjusting positions accordingly. A break above the 50-day SMA could signal a buying opportunity, while a drop below the 20-day SMA might indicate a sell signal.

Additional Sources for IHF ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

IHF ETF Overview

Market Cap in USD 632m
Category Health
TER 0.40%
IPO / Inception 2006-05-01

IHF ETF Ratings

Growth Rating 3.30
Fundamental -
Dividend Rating 40.6
Rel. Strength -23.1
Analysts -
Fair Price Momentum 39.34 USD
Fair Price DCF -

IHF Dividends

Dividend Yield 12m 0.91%
Yield on Cost 5y 1.18%
Annual Growth 5y 10.45%
Payout Consistency 61.2%
Payout Ratio %

IHF Growth Ratios

Growth Correlation 3m -72.1%
Growth Correlation 12m -80.6%
Growth Correlation 5y 33.4%
CAGR 5y 4.14%
CAGR/Max DD 5y 0.19
Sharpe Ratio 12m 0.11
Alpha -21.37
Beta 0.442
Volatility 27.54%
Current Volume 203.5k
Average Volume 20d 154.9k
Stop Loss 43.6 (-3.6%)
What is the price of IHF shares?
As of July 14, 2025, the stock is trading at USD 45.22 with a total of 203,507 shares traded.
Over the past week, the price has changed by -1.61%, over one month by -5.50%, over three months by -17.00% and over the past year by -13.57%.
Is iShares U.S. Healthcare a good stock to buy?
Neither. Based on ValueRay´s Analyses, iShares U.S. Healthcare is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 3.30 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IHF is around 39.34 USD . This means that IHF is currently overvalued and has a potential downside of -13%.
Is IHF a buy, sell or hold?
iShares U.S. Healthcare has no consensus analysts rating.
What are the forecasts for IHF share price target?
According to our own proprietary Forecast Model, IHF iShares U.S. Healthcare will be worth about 43.9 in July 2026. The stock is currently trading at 45.22. This means that the stock has a potential downside of -2.83%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 43.9 -2.8%